{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:41:41Z","timestamp":1772232101475,"version":"3.50.1"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>While antidepressants are routinely prescribed to manage depression, their long-term ramifications on reproductive health and the well-being of offspring are still shrouded in ambiguity. This review meticulously sifted through clinical trials pinpointing antidepressant usage among individuals of childbearing potential, highlighting safety concerns regarding reproductive health and the subsequent effects on offspring. We delved into studies spanning from January 1, 2000, to December 30, 2023, inclusively analyzing randomized controlled trials, cohort studies, and case-control studies. Our synthesis illuminates a concerning correlation between antidepressant intake and an array of sexual dysfunction. Among pregnant users, an alarming connection was noted with heightened incidences of miscarriage, preterm births, postpartum hemorrhage, and gestational diabetes mellitus. Newborns subjected to antidepressant exposure faced an elevated risk of low birth weight, more frequent admissions to neonatal intensive care units, being small for gestational age, malformation, and other adverse outcomes in newborns. The underpinning mechanisms triggering these adverse outcomes seem to intertwine with GABA receptor interactions, induced oxidative stress, and disruptions in mitotic spindle assembly. The surfacing evidence of antidepressants\u2019 potential reproductive toxicity underscores the need for circumspection in their prescribing practices. It becomes crucial to not only clearly communicate these risks to patients but also to tailor treatment decisions to meticulously balance individual needs against potential risks. Looking ahead, future endeavors should pivot toward a deeper understanding of the detrimental effects antidepressants may harbor reproductive health and offspring vitality. This necessitates devising innovative strategies that mitigate these risks, safeguarding treatment efficacy for generations to come.<\/jats:p>","DOI":"10.1093\/biolre\/ioaf156","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T11:20:37Z","timestamp":1753096837000},"page":"511-526","source":"Crossref","is-referenced-by-count":1,"title":["From parents to offspring: a comprehensive review of antidepressant-linked reproductive risks"],"prefix":"10.1093","volume":"113","author":[{"given":"Sixian","family":"Wu","sequence":"first","affiliation":[{"name":"Joint Laboratory of Reproductive Medicine, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yan","sequence":"additional","affiliation":[{"name":"Joint Laboratory of Reproductive Medicine, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazhen","family":"Wei","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingming","family":"Liu","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qixuan","family":"Yue","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University , Xiamen ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gelin","family":"Huang","sequence":"additional","affiliation":[{"name":"Joint Laboratory of Reproductive Medicine, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Li","sequence":"additional","affiliation":[{"name":"Joint Laboratory of Reproductive Medicine, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]},{"name":"Reproduction Medical Centre, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiliang","family":"Ji","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University , Xiamen ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Ni","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Sichuan University , Chengdu ,","place":["China"]},{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-229X","authenticated-orcid":false,"given":"Wenming","family":"Xu","sequence":"additional","affiliation":[{"name":"Joint Laboratory of Reproductive Medicine, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University , Chengdu ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"2025091917110097300_ref1","volume-title":"Depression"},{"key":"2025091917110097300_ref2","volume-title":"Depression and other Common Mental Disorders: Global Health Estimates","author":"World Health Organization","year":"2017"},{"key":"2025091917110097300_ref3","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"2025091917110097300_ref4","doi-asserted-by":"crossref","first-page":"8836983","DOI":"10.1155\/2020\/8836983","article-title":"The therapeutic prospects of naturally occurring and synthetic indole alkaloids for depression and anxiety disorders","volume":"2020","author":"Munir","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"2025091917110097300_ref5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jad.2020.05.149","article-title":"COVID-19 inpatients with psychiatric disorders: real-world clinical recommendations from an expert team in consultation-liaison psychiatry","volume":"274","author":"Anmella","year":"2020","journal-title":"J Affect Disord"},{"key":"2025091917110097300_ref6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/jehp.jehp_1032_20","article-title":"Social media exposure and mental health problems during coronavirus disease 2019 pandemic in Indonesia","volume":"10","author":"Lugito","year":"2021","journal-title":"J Educ Health Promot"},{"key":"2025091917110097300_ref7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/nu10080957","article-title":"Relationship between diet and mental health in a young adult Appalachian college population","volume":"10","author":"Wattick","year":"2018","journal-title":"Nutrients"},{"key":"2025091917110097300_ref8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fnins.2019.00229","article-title":"Subjecting dams to early life stress and perinatal fluoxetine treatment differentially alters social behavior in young and adult rat offspring","volume":"13","author":"Houwing","year":"2019","journal-title":"Front Neurosci"},{"key":"2025091917110097300_ref9","doi-asserted-by":"crossref","first-page":"2045125319872344","DOI":"10.1177\/2045125319872344","article-title":"Patients\u2019 attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators","volume":"9","author":"Eveleigh","year":"2019","journal-title":"Ther Adv Psychopharmacol"},{"key":"2025091917110097300_ref10","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1021\/acschemneuro.9b00180","article-title":"In utero exposure to citalopram mitigates maternal stress effects on fetal brain development","volume":"10","author":"Velasquez","year":"2019","journal-title":"ACS Chem Nerosci"},{"key":"2025091917110097300_ref11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fpsyt.2020.00551","article-title":"Trends in antidepressant use and expenditure in six major cities in China from 2013 to 2018","volume":"11","author":"Yu","year":"2020","journal-title":"Front Psych"},{"key":"2025091917110097300_ref12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/sj.bjp.0703222","article-title":"Blockade of the HERG human cardiac K(+) channel by the antidepressant drug amitriptyline","volume":"129","author":"Jo","year":"2000","journal-title":"Br J Pharmacol"},{"key":"2025091917110097300_ref13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neubiorev.2016.08.037","article-title":"The impact of treatment with selective serotonin reuptake inhibitors on primate cardiovascular disease, behavior, and neuroanatomy","volume":"74","author":"Shively","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"2025091917110097300_ref14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174247","article-title":"Fluoxetine suppresses glutamate- and GABA-mediated neurotransmission by altering SNARE complex","volume":"20","author":"Lazarevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025091917110097300_ref15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YIC.0000000000000075","article-title":"Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial","volume":"30","author":"Clayton","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"key":"2025091917110097300_ref16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.genhosppsych.2014.10.010","article-title":"Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial","volume":"37","author":"Khazaie","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"2025091917110097300_ref17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ijir.2011.35","article-title":"Escitalopram treatment for premature ejaculation has a negative effect on semen parameters","volume":"23","author":"Koyuncu","year":"2011","journal-title":"Int J Impot Res"},{"key":"2025091917110097300_ref18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/1933719110385708","article-title":"Semen parameters are unrelated to BMI but vary with SSRI use and prior urological surgery","volume":"18","author":"Relwani","year":"2011","journal-title":"Reprod Sci"},{"key":"2025091917110097300_ref19","doi-asserted-by":"crossref","first-page":"110231","DOI":"10.1016\/j.jpsychores.2020.110231","article-title":"Maternal use of antidepressants during pregnancy and risks for adverse perinatal outcomes: a meta-analysis","volume":"137","author":"Xing","year":"2020","journal-title":"J Psychosom Res"},{"key":"2025091917110097300_ref20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdra.20773","article-title":"Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy","volume":"91","author":"Colvin","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2025091917110097300_ref21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0269881117699361","article-title":"British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017","volume":"31","author":"McAllister-Williams","year":"2017","journal-title":"J Psychopharmacol"},{"key":"2025091917110097300_ref22","doi-asserted-by":"crossref","first-page":"e92778","DOI":"10.1371\/journal.pone.0092778","article-title":"Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis","volume":"9","author":"Huybrechts","year":"2014","journal-title":"PloS One"},{"key":"2025091917110097300_ref23","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"2025091917110097300_ref24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0006-3223(00)00957-4","article-title":"Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline","volume":"48","author":"Stahl","year":"2000","journal-title":"Biol Psychiatry"},{"key":"2025091917110097300_ref25","first-page":"151","article-title":"Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder","volume":"18","author":"Clayton","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"2025091917110097300_ref26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1743-6109.2007.00520.x","article-title":"Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder","volume":"4","author":"Clayton","year":"2007","journal-title":"J Sex Med"},{"key":"2025091917110097300_ref27","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/jsm.12004","article-title":"The effect of vilazodone on sexual function during the treatment of major depressive disorder","volume":"10","author":"Clayton","year":"2013","journal-title":"J Sex Med"},{"key":"2025091917110097300_ref28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.18m12132","article-title":"Effect of Lurasidone on sexual function in major depressive disorder patients with subthreshold hypomanic symptoms (mixed features): results from a placebo-controlled trial","volume":"79","author":"Clayton","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"2025091917110097300_ref29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00004714-200104000-00006","article-title":"Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care","volume":"21","author":"Ekselius","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"2025091917110097300_ref30","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.esxm.2016.04.002","article-title":"Serotonin reuptake inhibition, and plasma oxytocin in obsessive-compulsive disorder. Gleaning from a distant randomized clinical trial","volume":"4","author":"Humble","year":"2016","journal-title":"Sex Med"},{"key":"2025091917110097300_ref31","first-page":"1638","article-title":"Paroxetine, but not vortioxetine, impairs sexual functioning compared with placebo in healthy adults: a randomized","volume":"16","author":"Jacobsen","year":"2019","journal-title":"Controlled Trial J Sex Med"},{"key":"2025091917110097300_ref32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/JCP.0b013e318172b48c","article-title":"A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR","volume":"28","author":"Kennedy","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"2025091917110097300_ref33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.jcp.0000204138.20417.c3","article-title":"Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder","volume":"26","author":"Langworth","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"2025091917110097300_ref34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004714-200204000-00008","article-title":"Specific side effects of long-term imipramine management of panic disorder","volume":"22","author":"Mavissakalian","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"2025091917110097300_ref35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4088\/JCP.v62n0508","article-title":"Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial","volume":"62","author":"Pollack","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"2025091917110097300_ref36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41398-023-02435-0","article-title":"A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder","volume":"13","author":"Mi","year":"2023","journal-title":"Transl Psychiatry"},{"key":"2025091917110097300_ref37","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.juro.2008.07.034","article-title":"Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay","volume":"180","author":"Safarinejad","year":"2008","journal-title":"J Urol"},{"key":"2025091917110097300_ref38","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.fertnstert.2009.04.039","article-title":"Adverse effect of paroxetine on sperm","volume":"94","author":"Tanrikut","year":"2010","journal-title":"Fertil Steril"},{"key":"2025091917110097300_ref39","doi-asserted-by":"crossref","first-page":"911489","DOI":"10.3389\/fphar.2022.911489","article-title":"The effect of SSRIs on semen quality: a systematic review and meta-analysis","volume":"13","author":"Xu","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025091917110097300_ref40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.urology.2013.12.004","article-title":"Comparison of the effect of sertraline with behavioral therapy on semen parameters in men with primary premature ejaculation","volume":"83","author":"Akasheh","year":"2014","journal-title":"Urology"},{"key":"2025091917110097300_ref41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.urology.2022.01.026","article-title":"Selective serotonin reuptake inhibitor (SSRI) use is not associated with impaired semen parameters","volume":"164","author":"Pham","year":"2022","journal-title":"Urology"},{"key":"2025091917110097300_ref42","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","article-title":"Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study","volume":"192","author":"Chun-Fai-Chan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2025091917110097300_ref43","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/0091270011405524","article-title":"Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study","volume":"52","author":"Klieger-Grossmann","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"2025091917110097300_ref44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/phar.2308","article-title":"Association between first trimester antidepressant use and risk of spontaneous abortion","volume":"39","author":"Wu","year":"2019","journal-title":"Pharmacotherapy"},{"key":"2025091917110097300_ref45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.reprotox.2019.01.003","article-title":"Pregnancy outcomes following maternal venlafaxine use: a prospective observational comparative cohort study","volume":"84","author":"Richardson","year":"2019","journal-title":"Reprod Toxicol"},{"key":"2025091917110097300_ref46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1503\/cmaj.091208","article-title":"Use of antidepressants during pregnancy and the risk of spontaneous abortion","volume":"182","author":"Nakhai-Pour","year":"2010","journal-title":"Cmaj"},{"key":"2025091917110097300_ref47","doi-asserted-by":"crossref","first-page":"m237","DOI":"10.1136\/bmj.m237","article-title":"Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study","volume":"368","author":"Huybrechts","year":"2020","journal-title":"Bmj"},{"key":"2025091917110097300_ref48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1542-2011.2010.00023.x","article-title":"Maternal corticotropin-releasing hormone and the use of selective serotonin reuptake inhibitors independently predict the occurrence of preterm birth","volume":"56","author":"Latendresse","year":"2011","journal-title":"J Midwifery Womens Health"},{"key":"2025091917110097300_ref49","doi-asserted-by":"crossref","first-page":"49.e1","DOI":"10.1016\/j.ajog.2012.04.028","article-title":"Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies","volume":"207","author":"Hayes","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2025091917110097300_ref50","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1176\/appi.ajp.2015.14121575","article-title":"Pregnancy complications following prenatal exposure to SSRIs or maternal psychiatric disorders: results from population-based National Register Data","volume":"172","author":"Malm","year":"2015","journal-title":"Am J Psychiatry"},{"key":"2025091917110097300_ref51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/JCP.0b013e3182490eaf","article-title":"Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian mother and child cohort study","volume":"32","author":"Nordeng","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"2025091917110097300_ref52","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"key":"2025091917110097300_ref53","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/da.20883","article-title":"Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment","volume":"28","author":"Salisbury","year":"2011","journal-title":"Depress Anxiety"},{"key":"2025091917110097300_ref54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/appi.ajp.2015.14080989","article-title":"The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month","volume":"173","author":"Salisbury","year":"2016","journal-title":"Am J Psychiatry"},{"key":"2025091917110097300_ref55","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2017.3413","article-title":"Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring","volume":"317","author":"Sujan","year":"2017","journal-title":"Jama"},{"key":"2025091917110097300_ref56","article-title":"Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age","volume-title":"Int J Epidemiol","author":""},{"key":"2025091917110097300_ref57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7150\/ijms.5213","article-title":"Duloxetine and pregnancy outcomes: safety surveillance findings","volume":"10","author":"Hoog","year":"2013","journal-title":"Int J Med Sci"},{"key":"2025091917110097300_ref58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12884-017-1334-4","article-title":"Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study","volume":"17","author":"Heller","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025091917110097300_ref59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejogrb.2020.11.062","article-title":"The impact of major depressive disorder and antidepressant medication before and during pregnancy on obstetric and neonatal outcomes: a nationwide population-based study","volume":"257","author":"Wolgast","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025091917110097300_ref60","doi-asserted-by":"crossref","first-page":"e025908","DOI":"10.1136\/bmjopen-2018-025908","article-title":"Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case\u2013control study","volume":"9","author":"Dandjinou","year":"2019","journal-title":"BMJ Open"},{"key":"2025091917110097300_ref61","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/pds.4799","article-title":"Antidepressant continuation in pregnancy and risk of gestational diabetes","volume":"28","author":"Wartko","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025091917110097300_ref62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.reprotox.2020.04.010","article-title":"Risk of gestational diabetes mellitus after use of antidepressant medication in pregnancy: results from the Norwegian mother and child cohort study","volume":"97","author":"Lupattelli","year":"2020","journal-title":"Reprod Toxicol"},{"key":"2025091917110097300_ref63","doi-asserted-by":"crossref","first-page":"e64654","DOI":"10.1371\/journal.pone.0064654","article-title":"Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study","volume":"8","author":"Vries","year":"2013","journal-title":"PloS One"},{"key":"2025091917110097300_ref64","doi-asserted-by":"crossref","first-page":"579.e1","DOI":"10.1016\/j.ajog.2009.06.061","article-title":"Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy","volume":"201","author":"Calderon-Margalit","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"2025091917110097300_ref65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/JCP.0b013e31826686bc","article-title":"Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors","volume":"32","author":"Grzeskowiak","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"2025091917110097300_ref66","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","article-title":"Selective serotonin reuptake inhibitors and adverse pregnancy outcomes","volume":"194","author":"Wen","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"2025091917110097300_ref67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ppe.12721","article-title":"A population-based study of concurrent prescriptions of opioid analgesic and selective serotonin reuptake inhibitor medications during pregnancy and risk for adverse birth outcomes","volume":"35","author":"Sujan","year":"2021","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2025091917110097300_ref68","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41372-020-0598-0","article-title":"Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy-neonatal outcomes in correlation with placental histopathology","volume":"40","author":"Levy","year":"2020","journal-title":"J Perinatol"},{"key":"2025091917110097300_ref69","doi-asserted-by":"crossref","first-page":"k2233","DOI":"10.1136\/bmj.k2233","article-title":"Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study","volume":"361","author":"Viktorin","year":"2018","journal-title":"Bmj"},{"key":"2025091917110097300_ref70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1471-0528.2007.01518.x","article-title":"Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study","volume":"115","author":"Maschi","year":"2008","journal-title":"Bjog"},{"key":"2025091917110097300_ref71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/bfm.2016.0095","article-title":"Short-term safety of paroxetine and sertraline in breastfed infants: a retrospective cohort study from a university hospital","volume":"11","author":"Uguz","year":"2016","journal-title":"Breastfeed Med"},{"key":"2025091917110097300_ref72","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/pds.4242","article-title":"Use of antidepressant medication in pregnancy and adverse neonatal outcomes: a population-based investigation","volume":"26","author":"Cantarutti","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025091917110097300_ref73","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1192\/bjp.bp.107.037101","article-title":"Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study","volume":"192","author":"Oberlander","year":"2008","journal-title":"Br J Psychiatry"},{"key":"2025091917110097300_ref74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0032-1324697","article-title":"In utero antidepressant exposure and neurodevelopment in preterm infants","volume":"30","author":"Batton","year":"2013","journal-title":"Am J Perinatol"},{"key":"2025091917110097300_ref75","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00737-019-00954-8","article-title":"The effect of maternal antidepressants on third trimester uteroplacental hemodynamics and the neonatal abstinence syndrome: a retrospective cohort study","volume":"22","author":"McLean","year":"2019","journal-title":"Arch Womens Ment Health"},{"key":"2025091917110097300_ref76","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archgenpsychiatry.2012.160","article-title":"Prenatal antipsychotic exposure and neuromotor performance during infancy","volume":"69","author":"Johnson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"2025091917110097300_ref77","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2017.1727","article-title":"Association of antidepressant medication use during pregnancy with intellectual disability in offspring","volume":"74","author":"Viktorin","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2025091917110097300_ref78","doi-asserted-by":"crossref","first-page":"e1241","DOI":"10.1542\/peds.2013-3406","article-title":"Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay","volume":"133","author":"Harrington","year":"2014","journal-title":"Pediatrics"},{"key":"2025091917110097300_ref79","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.earlhumdev.2008.06.008","article-title":"Hypothalamic-pituitary-adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure","volume":"84","author":"Oberlander","year":"2008","journal-title":"Early Hum Dev"},{"key":"2025091917110097300_ref80","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/EDE.0000000000000157","article-title":"Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot","volume":"25","author":"Yazdy","year":"2014","journal-title":"Epidemiology"},{"key":"2025091917110097300_ref81","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N Engl J Med"},{"key":"2025091917110097300_ref82","first-page":"1","article-title":"Analysis of adverse reactions of aspirin in prophylaxis medication based on FAERS database","volume":"2022","author":"Ren","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"2025091917110097300_ref83","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.7326\/M21-3393","article-title":"Moving the U.S. Food and Drug Administration forward","volume":"174","author":"Perlmutter","year":"2021","journal-title":"Ann Intern Med"},{"key":"2025091917110097300_ref84","first-page":"62","article-title":"Benzodiazepines related sexual dysfunctions: a critical review on pharmacology and mechanism of action","volume":"19","author":"Hosseinzadeh Zoroufchi","year":"2021","journal-title":"Rev Int Androl"},{"key":"2025091917110097300_ref85","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4103\/1008-682X.192637","article-title":"Sertraline-induced reproductive toxicity in male rats: evaluation of possible underlying mechanisms","volume":"19","author":"Atli","year":"2017","journal-title":"Asian J Androl"},{"key":"2025091917110097300_ref86","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ijms222111855","article-title":"Molecular consequences of depression treatment: a potential in vitro mechanism for antidepressants-induced reprotoxic side effects","volume":"22","author":"So\u0142ek","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025091917110097300_ref87","article-title":"Toxic effect of antidepressants on male reproductive system cells: evaluation of possible fertility reduction mechanism","volume":"72","author":"Solek","year":"2021","journal-title":"J Physiol Pharmacol"},{"key":"2025091917110097300_ref88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.103.063362","article-title":"Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model","volume":"310","author":"Angulo","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"2025091917110097300_ref89","doi-asserted-by":"crossref","first-page":"467.e1","DOI":"10.1016\/j.ajog.2022.10.007","article-title":"Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes","volume":"228","author":"Habelrih","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"2025091917110097300_ref90","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.3389\/fimmu.2018.02966","article-title":"Inhibition of inflammatory changes in human myometrial cells by cell penetrating peptide and small molecule inhibitors of NFkappaB","volume":"9","author":"Gurney","year":"2018","journal-title":"Front Immunol"},{"key":"2025091917110097300_ref91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.psyneuen.2017.02.027","article-title":"Lower inflammatory markers in women with antenatal depression brings the M1\/M2 balance into focus from a new direction","volume":"80","author":"Edvinsson","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"2025091917110097300_ref92","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081306","article-title":"Effect of selected antidepressants on placental homeostasis of serotonin: maternal and fetal perspectives","volume":"13","author":"Horackova","year":"2021","journal-title":"Pharmaceutics"},{"key":"2025091917110097300_ref93","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acschemneuro.3c00621","article-title":"Sex-specific transcriptomic changes in the villous tissue of placentas of pregnant women using a selective serotonin reuptake inhibitor","volume":"15","author":"Staal","year":"2024","journal-title":"ACS Chem Nerosci"},{"key":"2025091917110097300_ref94","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.intimp.2017.06.031","article-title":"IL-27 induces a pro-inflammatory response in human fetal membranes mediating preterm birth","volume":"50","author":"Yin","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"2025091917110097300_ref95","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1039\/c8tx00102b","article-title":"Maternal SSRIs experience and risk of ASD in offspring: a review","volume":"7","author":"Fatima","year":"2018","journal-title":"Toxicol Res (Camb)"},{"key":"2025091917110097300_ref96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/toxics10010011","article-title":"Effect of low and high doses of two selective serotonin reuptake inhibitors on pregnancy outcomes and neonatal mortality","volume":"10","author":"Domingues","year":"2022","journal-title":"Toxics"},{"key":"2025091917110097300_ref97","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2016.11.021","article-title":"Fluoxetine and its active metabolite norfluoxetine disrupt estrogen synthesis in a co-culture model of the feto-placental unit","volume":"442","author":"Hudon Thibeault","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"2025091917110097300_ref98","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1093\/humrep\/deab190","article-title":"The antidepressant sertraline inhibits CatSper Ca2+ channels in human sperm","volume":"36","author":"Rahban","year":"2021","journal-title":"Hum Reprod"},{"key":"2025091917110097300_ref99","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s43032-024-01760-z","article-title":"Fluoxetine mitigates human sperm quality by disrupting the antioxidant defense system and altering the expression of apoptosis-related genes: an in vitro study","volume":"32","author":"Roostaee","year":"2025","journal-title":"Reprod Sci"},{"key":"2025091917110097300_ref100","doi-asserted-by":"crossref","first-page":"172774","DOI":"10.1016\/j.ejphar.2019.172774","article-title":"Fluoxetine and sertraline effects on rat distal cauda epididymis contraction, sperm count and sperm transit time trough epididymis","volume":"865","author":"Bezerra","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"2025091917110097300_ref101","doi-asserted-by":"crossref","first-page":"e0271217","DOI":"10.1371\/journal.pone.0271217","article-title":"Paroxetine treatment in an animal model of depression improves sperm quality","volume":"17","author":"Aghajani","year":"2022","journal-title":"PloS One"},{"key":"2025091917110097300_ref102","first-page":"35","article-title":"The effects of exposure to fluoxetine during lactation on testicular tissue and sperm parameters in mice offspring","volume":"11","author":"Karimipour","year":"2020","journal-title":"Vet Res Forum"},{"key":"2025091917110097300_ref103","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28227594","article-title":"Antidepressants as autophagy modulators for cancer therapy","volume":"28","author":"He","year":"2023","journal-title":"Molecules"},{"key":"2025091917110097300_ref104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/AQTF4490","article-title":"Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children","volume":"27","author":"Heuvelman","year":"2023","journal-title":"Health Technol Assess"},{"key":"2025091917110097300_ref105","first-page":"127","article-title":"A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring\u2019s outcomes","volume":"21","author":"Prady","year":"2018","journal-title":"Arch Womens Ment Health"},{"key":"2025091917110097300_ref106","first-page":"2018","article-title":"Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study","volume":"45","author":"Nezvalova-Henriksen","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2025091917110097300_ref107","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuroscience.2021.05.023","article-title":"Early developmental exposure to fluoxetine and citalopram results in different neurodevelopmental outcomes","volume":"467","author":"Liu","year":"2021","journal-title":"Neuroscience"},{"key":"2025091917110097300_ref108","doi-asserted-by":"crossref","first-page":"e013372","DOI":"10.1136\/bmjopen-2016-013372","article-title":"Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec pregnancy cohort","volume":"7","author":"Berard","year":"2017","journal-title":"BMJ Open"},{"key":"2025091917110097300_ref109","doi-asserted-by":"crossref","first-page":"848581","DOI":"10.3389\/fmed.2022.848581","article-title":"Pregnancy complications and neonatal mortality in a serotonin transporter null mouse model: insight into the use of selective serotonin reuptake inhibitor during pregnancy","volume":"9","author":"Domingues","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025091917110097300_ref110","first-page":"e71678","article-title":"Impact of beta-blocker therapy on pregnant women with long QT syndrome: a systematic review","volume":"16","author":"Alrabadi","year":"2024","journal-title":"Cureus"},{"key":"2025091917110097300_ref111","doi-asserted-by":"crossref","first-page":"S855","DOI":"10.1016\/j.ajog.2017.12.004","article-title":"Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy","volume":"218","author":"McCowan","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2025091917110097300_ref112","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s13224-019-01278-4","article-title":"Fetal growth restriction","volume":"70","author":"Shrivastava","year":"2020","journal-title":"J Obstet Gynaecol India"},{"key":"2025091917110097300_ref113","first-page":"486","article-title":"Fetal growth restriction before and after birth","volume":"104","author":"Westby","year":"2021","journal-title":"Am Fam Physician"},{"key":"2025091917110097300_ref114","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/AOG.0000000000004251","article-title":"Fetal growth restriction: ACOG practice bulletin, number 227","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2025091917110097300_ref115","doi-asserted-by":"crossref","first-page":"S700","DOI":"10.1016\/j.ajog.2017.12.014","article-title":"Fetal growth velocity and body proportion in the assessment of growth","volume":"218","author":"Hiersch","year":"2018","journal-title":"Am J Obstet Gynecol"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioaf156\/63817899\/ioaf156.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/113\/3\/511\/63817899\/ioaf156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/113\/3\/511\/63817899\/ioaf156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:11:21Z","timestamp":1758316281000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/113\/3\/511\/8210289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":115,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,22]]},"published-print":{"date-parts":[[2025,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioaf156","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,7,22]]}}}